Registered Members Login:
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

4578 Pages (Click to Jump) V  < 1 2 3 4 5 6 7 > »    
Reply to this topic

post Posted: Aug 21 2019, 06:01 AM
  Quote Post

Posts: 405
Thanks: 739

In Reply To: rabbitrun's post @ Aug 21 2019, 05:38 AM

FDA is measured internally on hitting that PDUFA date. In that list of date differentials I posted earlier, it's rounded to every two weeks in the spreadsheet with a complicated time/date formula, but almost all those results are within 3 days of the rounded result anyway.

Doesn't it seem odd that they always hit the date or earlier in such a complicated team effort of evaluating a drug? Why is their miss ratio so low? Well, I read somewhere a long time ago that FDA is under high scrutiny internally based on performance metrics on hitting those dates.

The inference of this from my own conjecture is that the PDUFA extension mechanism is just a function to keep their metrics looking good. Otherwise why even bother with an extension. With the pressure to keep "fast tracked" drugs within parameters (can't keep extending priority drugs, looks bad), and crossing this with internal FDA performance metrics, I think there is a higher chance of rejection than extension. They don't want to extend our go over. Approval chances on our before PDUFA deadline.... 96%. Rejection... 3%. Extension or missed date... 1%.

Said 'Thanks' for this post: odi01  gerritbakker57  oystercatcher  rabbitrun  Johnny H  Farleap11  
post Posted: Aug 21 2019, 05:56 AM
  Quote Post

Posts: 120
Thanks: 371

In Reply To: rabbitrun's post @ Aug 21 2019, 05:38 AM

Just checked. Drugs from that list were all approved essentially on the PDUFA date. One was ~2 weeks early. Wouldn’t get too excited but it does bode very well for Scenesse approval.

Said 'Thanks' for this post: rabbitrun  Johnny H  Farleap11  
post Posted: Aug 21 2019, 05:38 AM
  Quote Post

Posts: 873
Thanks: 923

In Reply To: Johnny H's post @ Aug 21 2019, 04:46 AM

So that list of companies that received extensions were approved within that extra three month window -- were any of them actually approved before the revised date?

post Posted: Aug 21 2019, 04:58 AM
  Quote Post

Posts: 1,305
Thanks: 1358

In Reply To: Johnny H's post @ Aug 21 2019, 04:46 AM

Logically, you wouldn’t think they’d extend a deadline on something they didn’t anticipate approving. Agencies aren’t always logical.

Johnny H
post Posted: Aug 21 2019, 04:46 AM
  Quote Post

Posts: 670
Thanks: 1071

I did a quick google search of PDUFA extensions to see how common it is, and what the outcome generally is.

The first 3 pages of results led me to:






Selinexor, and


All received a 3 month PDUFA extension, and then were later approved in that 3 month window(1st cycle approval, no CRL).

In addition, Xeris Pharmaceuticals received a 3 month PDUFA extension for the FDA review of Gvoke. New PDUFA date is September 10th, 2019. The language in their investor press release is interesting:

"According to FDA’s current PDUFA Performance Goals, an FDA decision to extend the review period typically is limited to situations where review of the new information could address an outstanding issue(s) and lead to approval in the current review cycle."

Perhaps we're in an even better position for approval than I had previously thought (in my opinion, chances for approval were already above 90%).

Does anyone know of a drug that received a 3 month PDUFA extension and then was later denied? I haven't found one yet. I'll keep looking.

Clinuvel until my bowels release for the last time.

Said 'Thanks' for this post: odi01  rabbitrun  Farleap11  Verharven  Texas T  oystercatcher  totallysour  Billy Boots  endymion96  Kalaz  Alaaf  
post Posted: Aug 20 2019, 11:18 PM
  Quote Post

Posts: 1,305
Thanks: 1358

I predicted Aug 21 as liftoff date. Hope it holds true


post Posted: Aug 20 2019, 11:05 PM
  Quote Post

Posts: 106
Thanks: 164

A couple more Mutual and Institutional Funds have been added to the major holders list as from 31 July 2019.

post Posted: Aug 20 2019, 10:08 PM
  Quote Post

Posts: 364
Thanks: 759

In Reply To: Clinhope's post @ Aug 20 2019, 09:30 PM

You may want to check out bitcoin or gold forums. That is usually where there is lots of cash activism.

post Posted: Aug 20 2019, 09:30 PM
  Quote Post

Posts: 997
Thanks: 1103

Hopefully my post about the cash ban and the few scraps that have appeared in the MSM have got some peoples attention on this forum.

If any of you who think the "powers that be" have gone and are going too far with their monetary policies please sign this petition. It would be great if more people would contact their local members but i understand not everyone sees this the same as i do.


This is a battle against international conglomerate banks like HSBC who are petitioning the government to lower the amount to well below $10,000. They have vested interests in seeing this through.

These banks, governments and financial institutions play monopoly with real peoples livelihoods and lives. NO MORE. The next GFC will come because of these scumbags and everyday people will suffer. They are vying to set up the monetary policies around the world so that they can keep playing these games!


Member of the “ALL-IN” club 2018.

Said 'Thanks' for this post: endymion96  
post Posted: Aug 20 2019, 09:23 PM
  Quote Post

Posts: 515
Thanks: 422

In Reply To: LevelHeaded2000's post @ Aug 20 2019, 06:42 PM

Judging by the relatively large sell orders appearing out of nowhere today which were snapped up in due haste, I don’t think these guys are worried. Of course it’s good to see them buying on the market but this is far too robotic to be coincidental. My investment is at the mercy of professionals’ whims. Such is life...


4578 Pages (Click to Jump) V  < 1 2 3 4 5 6 7 > » 

Back To Top Of Page
Reply to this topic

You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.